Close Menu

In Genome Biology this week, a team of researchers in Germany compared target genes of TFIIB and NC2 transcription factors in human B cells and analyzed the associated core promoter architectures. TFIIB occupancy is positively correlated with gene expression, the researchers write, and the majority of promoters are GC-rich and lack defined core promoter elements. They also found that NC2 binds to a highly related target gene set. "TFIIB and NC2 are global players that occupy active genes," the team writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novamax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.